About Index Trending news
Analyze
Top 50 Pricing
MabVax Therapeutics

MabVax Therapeutics

Work at MabVax Therapeutics? Add yourself to this profile

MabVax Therapeutics

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$11,600,000
Private equity
$3,000,000
Employees

Team size

2
Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when MabVax Therapeutics makes some noise.